Developer of a next generation DNA sequencing therapy designed to detect ultra-rare variants of DNA molecules that are invisible by other sequencing approaches. The company's technique uses specialized adapters to uniquely tag both strands of individual DNA duplexes in a population, sequence and using proprietary software, read both strands of individual DNA molecules enabling researchers to get a new generation of high-accuracy clinical diagnostics and innovative tools for scientific discovery.